{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:46:44Z","timestamp":1781070404246,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.amjmed.2017.12.034","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T09:00:18Z","timestamp":1522400418000},"page":"484-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Severe Asthma in Primary Care: Identification and Management"],"prefix":"10.1016","volume":"131","author":[{"given":"Jennifer L.","family":"Trevor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Chipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.12.034_bib0010","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0015","series-title":"Asthma Facts\u2014CDC's National Asthma Control Program Grantees","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaci.2012.04.014","article-title":"Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study","volume":"130","author":"Chipps","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40413-016-0131-2","article-title":"Asthma heterogeneity and severity","volume":"9","author":"Carr","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/thoraxjnl-2013-204815","article-title":"The association between childhood asthma and adult chronic obstructive pulmonary disease","volume":"69","author":"Tai","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0040","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of growth and decline in lung function in persistent childhood asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2466-9-24","article-title":"Economic burden of asthma: a systematic review","volume":"9","author":"Bahadori","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JAA.S134300","article-title":"Asthma referrals: a key component of asthma management that needs to be addressed","volume":"10","author":"Price","year":"2017","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/JMDH.S22966","article-title":"Helping patients attain and maintain asthma control: reviewing the role of the nurse practitioner","volume":"4","author":"Rance","year":"2011","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2500\/aap.2011.32.3518","article-title":"Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey","volume":"33","author":"Murphy","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0070","author":"Schierhorn"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1378\/chest.12-0412","article-title":"The poorly explored impact of uncontrolled asthma","volume":"143","author":"O'Byrne","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCP.0000000000000225","article-title":"Asthma phenotypes and endotypes: a personalized approach to treatment","volume":"22","author":"Skloot","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0085","author":"Global Initiative for Asthma"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0090","series-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007","article-title":"National asthma education and prevention program","author":"National Heart, Lung and Blood Institute","year":"2007"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0095","first-page":"e323","article-title":"A health plan's investigation of Healthy Days and chronic conditions","volume":"23","author":"Cordier","year":"2017","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0100","author":"Qoltech"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"Identifying \u201cwell-controlled\u201d and \u201cnot well-controlled\u201d asthma using the Asthma Control Questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0110","author":"Optum"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0120","first-page":"359","article-title":"A stepwise approach to the interpretation of pulmonary function tests","volume":"89","author":"Johnson","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0125","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3438","article-title":"Clinical tools to assess asthma control in children","volume":"139","author":"Dinakar","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/IJGM.S7319","article-title":"The use of spirometry in a primary care setting","volume":"2","author":"Blain","year":"2009","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thoraxjnl-2015-207630","article-title":"Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry","volume":"71","author":"Sweeney","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0140","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2013.04.052","article-title":"Severe adult-onset asthma: a distinct phenotype","volume":"132","author":"Amelink","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40413-016-0130-3","article-title":"Therapeutic interventions in severe asthma","volume":"9","author":"Canonica","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cea.12880","article-title":"Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications","volume":"47","author":"Robinson","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaip.2017.01.026","article-title":"Asthma control and sputum eosinophils: a longitudinal study in daily practice","volume":"5","author":"Demarche","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anai.2016.12.010","article-title":"Asthma Yardstick: practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma","volume":"118","author":"Chipps","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fimmu.2017.00242","article-title":"Reslizumab and eosinophilic asthma: one step closer to precision medicine?","volume":"8","author":"Varricchi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2017.9.1.3","article-title":"Development of new therapies for severe asthma","volume":"9","author":"Fajt","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0180","series-title":"XOLAIR (Omalizumab Injection), Solution for Subcutaneous Use [package insert]","author":"Genentech, Inc.","year":"2017"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0185","series-title":"NUCALA (Mepolizumab Injection), Solution for Subcutaneous Use [package insert]","author":"GlaxoSmithKline LLC","year":"2017"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0195","series-title":"CINQAIR (Reslizumab Injection), Solution for Subcutaneous Use [package insert]","author":"Teva Respiratory, LLC","year":"2016"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0190","series-title":"FASENRA (Benralizumab) [package insert]","author":"AstraZeneca AB","year":"2017"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0200","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0210","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0215","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0220","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0225","series-title":"Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma","author":"AstraZeneca","year":"2017"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0235","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.12.034_bib0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.anai.2015.11.002","article-title":"Bronchial thermoplasty: a review of the evidence","volume":"116","author":"Wilhelm","year":"2016","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431830024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431830024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:14:27Z","timestamp":1757582067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431830024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S000293431830024X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.034","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Asthma in Primary Care: Identification and Management","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}